NeoGenomics: Dave Daly
NeoGenomics has appointed Dave Daly to its board of directors, effective Nov. 10. Daly is the president and COO of sequencing firm Singular Genomics and previously served as CEO at Thrive Earlier Detection, a company acquired by Exact Sciences earlier this year. He also worked at Illumina as SVP and general manager of of commercial operations for the Americas, Foundation Medicine and Clarient as CCO, and Life Technologies, where he led the oncology business unit.
Daly also served in positions at Roche Diagnostics and Abbott.